The best thing I found in America is that my research interest was welcomed by a lot of research scientists, and they readily cooperated with my ideas and whatever I needed. It was easier when I was doing the clinical practice. But when I started my own company, I found it difficult for anybody to collaborate, because it's a very expensive proposition. So I just concentrated on myself.
I financed myself. I've been steadily investing my own money in biotechnology from 1980 onward. A major investment came in 2010 when I got a grant from the federal government, and another investment came during COVID when I made $22 million in stock market. Much of the money is invested already. It's my belief that I should do what my mind and goal desires, because we have one life to live. We should do whatever we want to do.
I've written one chapter in a book on breast cancer, the project is by an award-winning British writer. I explain the current advances in breast cancer limitations and how my technology could help. I also have a book chapter in Fundamentals of Immunology and its applications.
Later this month I am keynote speaker in Paris for a conference on re-engineering diabetes. Re-engineering diabetes is a different way of treating diabetes, where complications of diabetes are not related to A1C, but directly through immune interactions.
I am greatly excited about the future of artificial intelligence that is evolving in both the USA and India. AI is "Aladdin's Lamp" for future generations. With rightful engineering prompts, artificial intelligence acts as a magic genie. It allows us to visualize flaws in current systems and help define the future products and services in different fields. I am dedicated to advancing global healthcare. I leverage artificial intelligence to advance life saving, futuristic space age products and services that can be implemented with "Zero Tolerance to time" using "Right to Try Law' in the USA. In future, I expect this law will be implemented to meet the global needs.
I am in the process of forming ETBONDAI private limited company in India to streamline my advances through clinical trials in diabetes.
(Photo: The SATimes)
